Medinet Co Ltd
TSE:2370

Watchlist Manager
Medinet Co Ltd Logo
Medinet Co Ltd
TSE:2370
Watchlist
Price: 40 JPY Market Closed
Market Cap: 10.6B JPY
Have any thoughts about
Medinet Co Ltd?
Write Note

Medinet Co Ltd
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Medinet Co Ltd
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Medinet Co Ltd
TSE:2370
Other Long-Term Assets
-ÂĄ465.5m
CAGR 3-Years
-5%
CAGR 5-Years
13%
CAGR 10-Years
N/A
CMIC Holdings Co Ltd
TSE:2309
Other Long-Term Assets
ÂĄ8.9B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
11%
C
Chiome Bioscience Inc
TSE:4583
Other Long-Term Assets
ÂĄ134.4m
CAGR 3-Years
4%
CAGR 5-Years
11%
CAGR 10-Years
6%
Precision System Science Co Ltd
TSE:7707
Other Long-Term Assets
ÂĄ11.9m
CAGR 3-Years
-57%
CAGR 5-Years
-13%
CAGR 10-Years
-15%
CellSource Co Ltd
TSE:4880
Other Long-Term Assets
ÂĄ459.8m
CAGR 3-Years
70%
CAGR 5-Years
34%
CAGR 10-Years
N/A
WDB coco Co Ltd
TSE:7079
Other Long-Term Assets
ÂĄ223.3m
CAGR 3-Years
14%
CAGR 5-Years
33%
CAGR 10-Years
N/A
No Stocks Found

Medinet Co Ltd
Glance View

Market Cap
10.3B JPY
Industry
Life Sciences Tools & Services

MEDINET Co., Ltd. engages in cell processing business. The company is headquartered in Ota-Ku, Tokyo-To and currently employs 83 full-time employees. The company went IPO on 2003-10-08. The company operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. The company also provides comprehensive support services for immune cell therapy.

Intrinsic Value
7.7 JPY
Overvaluation 81%
Intrinsic Value
Price

See Also

What is Medinet Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
-465.5m JPY

Based on the financial report for Jun 30, 2024, Medinet Co Ltd's Other Long-Term Assets amounts to -465.5m JPY.

What is Medinet Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
13%

Over the last year, the Other Long-Term Assets growth was -17%. The average annual Other Long-Term Assets growth rates for Medinet Co Ltd have been -5% over the past three years , 13% over the past five years .

Back to Top